Patents by Inventor Chi-Young Chang

Chi-Young Chang has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20040097534
    Abstract: Disclosed is a composition for protecting nerve cells, promoting nerve cell growth and regenerating nerve cells comprising berberine, derivatives thereof or pharmaceutically acceptable salts thereof. The composition has protective effects against apoptosis of neuronal stem cells and differentiated neuronal stem cells, an effect of inducing the regeneration of nerve cells, a regenerative effect on neurites, a neuroregenerative effect on central nerves and peripheral nerves, a reformation effect on neuromuscular junctions, and a protective effect against apoptosis of nerve cells and a neuroregenerative effect in animals suffering from dementia and brain ischemia. Therefore, the composition can be used as a therapeutic agent for the prevention and treatment of neurodegenerative diseases, ischemic nervous diseases or nerve injuries, and for the improvement of learning capability.
    Type: Application
    Filed: March 14, 2003
    Publication date: May 20, 2004
    Applicant: EUGENBIO INC.
    Inventors: Byung-Kil Choi, Yun-Hee Kim, Soo-Kyung Kim, Jung-Su Lim, Hyo-Sup Kim, Dae-Sung Park, Chi-Young Chang
  • Publication number: 20030224074
    Abstract: Disclosed is a composition for protecting nerve cells, promoting nerve cell growth and regenerating nerve cells comprising a Scutellaria Radix extract. The composition has excellent protective effects against apoptosis of neuronal stem cells and differentiated nerve cells, a positive effect of inducing the regeneration of nerve cells, a regenerative effect on neurites, a neuroregenerative effect on brain nerves and peripheral nerves, a reformation effect on neuromuscular junctions, and a protective effect agaisnt apoptosis of nerve cells and a neuroregenerative effect in animals suffering from dementia and brain ischemia. Therefore, the composition can be used as a therapeutic agent for the prevention and treatment of nerodegenerative diseases, ischemic nervous diseases or nerve injuries, and for the improvement of learning capability.
    Type: Application
    Filed: March 14, 2003
    Publication date: December 4, 2003
    Applicant: EUGENBIO INC.
    Inventors: Byung-Kil Choe, Yun-Hee Kim, Soo-Kyung Kim, Jung-Su Lim, Hyo-Sup Kim, Dae-Sung Park, Chi-Young Chang